Philips VeriSight Pro 3D ICE catheter supports first patient cases in Europe
First procedures at University Medical Center Mainz and Robert Bosch Hospital Stuttgart showcase real-time intracardiac imaging
Jun 13, 2025 | 1 minute read
About the author About the author
I’m deeply motivated to elevate patient care in Structural Heart by advancing imaging precision with VeriSight Pro 3D ICE—bringing clarity, confidence, and compassion into every procedure.
You are about to visit a Philips global content page
Continue We are proud to announce that the first procedures in Europe using the recently launched Philips VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter have successfully been completed at the German University Medical Center Mainz and Robert Bosch Hospital in Stuttgart.
Dr. Philipp Nikolai and his team at Robert-Bosch Krankenhaus Stuttgart, Germany
VeriSight Pro is a miniaturized, steerable catheter with a high-resolution 3D ultrasound probe at its tip, offering detailed visualization of cardiac anatomy via femoral vein access.
At the University Medical Center Mainz, the team led by Prof. Stephan von Bardeleben and Prof. Philip Lurz used VeriSight Pro to guide tricuspid valve repair procedures, marking a European first in clinical use.
Prof. Dr. Ralph Stephan von Bardeleben, Dr. Tobias Ruf, and Dr. Theresa Gößler at University Medical Center Mainz, Germany
“The VeriSight Pro 3D ICE catheter allowed us to visualize the tricuspid valve in real-time with exceptional clarity, directly from within the heart,” said Prof. von Bardeleben. “This innovation helped us guide the procedure more confidently and efficiently — all without the need for general anesthesia. For our patients, this means a safer, faster recovery.”
Physicians highlight the superior image quality delivered by the EPIQ CVxi Ultrasound System
Meanwhile, at Robert Bosch Hospital in Stuttgart, Dr. Philipp Nikolai and his team successfully used VeriSight Pro for both tricuspid and mitral valve interventions, demonstrating its versatility across structural heart procedures.
“Performing both tricuspid and mitral valve interventions with the support of VeriSight Pro demonstrated the true potential of real-time 3D ICE,” said Dr. Nikolai. “It gave us clear, intraprocedural guidance during leaflet grasping, which is a key step in TEER procedures. This technology offers an alternative to TEE that is not only less invasive but also more efficient for the clinical team.”
Prof. Jens-Erik Nielsen Kudsk, Dr. Kasper Kolsholm, and Dr. Asger Andersen at Aarhus University Hospital, Denmark
The availability of Philips VeriSight Pro 3D ICE in Europe is an important milestone in helping more patients benefit from image-guided, minimally invasive heart procedures, while supporting care teams with integrated solutions that adapt to the way they work.
